Panacur Equine Granules 22.2 % w/w

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

Fenbendazole

제공처:

Intervet Ireland Limited

ATC 코드:

QP52AC13

INN (International Name):

Fenbendazole

복용량:

22.2 percent weight/weight

약제 형태:

Granules

처방전 유형:

POM: Prescription Only Medicine as defined in relevant national legislation

치료 그룹:

Horses

치료 영역:

fenbendazole

치료 징후:

Endoparasiticide

승인 상태:

Authorised

승인 날짜:

1999-10-01

제품 특성 요약

Health Products Regulatory Authority
24 November 2017
CRN000VD4
Page 1 of 5
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Panacur Equine Granules 22.2 % w/w
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each g contains:
​
​
ACTIVE SUBSTANCE:
​
​
Fenbendazole
​222 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Granules.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses and other equines.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of immature and mature stages of nematodes of the
gastro-intestinal and respiratory tracts of horses and other equines.
Sensitive endoparasites include adult and immature (larval) stages of:
Large strongyles
Small strongyles
Ascarids
_Oxyuris equi_
_Dictyocaulus arnfeldi_
Panacur is effective for the treatment of migrating strongyle
infections and inhibited
cyathostome larvae in the large intestine mucosa.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance.
Health Products Regulatory Authority
24 November 2017
CRN000VD4
Page 2 of 5
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:
- Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
- Underdosing, which may be due to underestimation of body weight,
misadministration of the product, or lack of calibration of the dosing
device.
Suspected clinical cases of resistance to anthelmintics should be
further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where
the results of
the test(s) strongly suggest resistance to a particular anthelmintic,
an anthelmintic
belonging to another pharmacological class and having a different mode
of action
should be used.
Resistance to benzimidazoles has been reported in gastro-intestinal
nematodes in
horses. Therefore, the use of this product should be based on local
epidemiological